Imidazole Propionate is Increased in Diabetes and Associated with Stool Consistency

BACKGROUND: Imidazole Propionate (ImP) is a new marker of Type 2 diabetes mellitus (T2DM), which can induce impaired glucose metabolism and weaken the efficacy of metformin. An extensive exploration into literature suggests that ImP may be associated with stool consistency. PURPOSE: Through an in-de...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Bowen, Tan, Li, Wang, Weihua, Feng, Xingzhong, Yan, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188368/
https://www.ncbi.nlm.nih.gov/pubmed/35698651
http://dx.doi.org/10.2147/DMSO.S362715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188368/
https://www.ncbi.nlm.nih.gov/pubmed/35698651
http://dx.doi.org/10.2147/DMSO.S362715

Ejemplares similares